APFED’s Executive Director Recognized with 2023 AAAAI Distinguished Layperson Award
February 25, 2023
Strobel received the award during the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)
ATLANTA, GA —The American Partnership for Eosinophilic Disorders (APFED) today announced that the American Academy of Allergy, Asthma and Immunology (AAAAI) has awarded APFED Executive Director Mary Jo Strobel with its 2023 Distinguished Layperson Award for her unwavering support and advocacy for eosinophilic disorders. The award was presented today during the 2023 AAAAI Annual Meeting in San Antonio, Texas.
Ms. Strobel has 25 years of professional experience in patient advocacy for allergic conditions and has served as APFED’s Executive Director since 2012. Ms. Strobel also has a broad background in patient education, awareness campaigns, and research, in addition to her achievements in advocacy.
Ms. Strobel has educated members of the U.S. Congress to encourage federal funding for research for eosinophil-associated disease and has encouraged their support for legislation for insurance reimbursement of medical foods and step therapy reform. She was recently involved in the development and publication of a global patient charter to inspire policymakers and healthcare decision-makers to reform healthcare practices for people living with eosinophil-associated diseases and has educated managed care and payer professionals about the clinical and economic burden of EoE, current and emerging treatments, and the importance of early diagnosis and multidisciplinary care.
Ms. Strobel has also been involved in initiatives to provide the U.S. Food and Drug Administration with patient experience so that they are informed as they consider applications for new treatments and to inspire drug developers to consider new areas of research.
The AAAAI is the leading membership organization of more than 7,000 healthcare professionals with a special interest in the research and treatment of allergic and immunologic diseases. View the 2023 AAAAI Honorary Award Recipients.
About the American Partnership for Eosinophilic Disorders (APFED)
The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. www.apfed.org
About the American Academy of Allergy, Asthma & Immunology (AAAAI)
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,000 members in the United States, Canada and 72 other countries. www.aaaai.org/